Irritable bowel syndrome (IBS) affects approximately 20% of the general population, primarily women. It is a chronic functional gastrointestinal disorder in which the patient’s gut microbiota differs significantly from that of healthy individuals. IBS significantly affects the patient’s quality of life and thus needs a stringent management strategy. However, recent advances in diagnostics and therapeutic interventions have made IBS management relatively easier. To know more about this topic, join Dr.
Satish Midha in our exclusive session on “Current Trends in Managing Irritable Bowel Syndrome” on 20 th November 2023, 3:00 PM IST onwards. Stay tuned for more! Suggested for you Antidepressant as a Therapeutic for IBS Bile and Fat Excretion Biomarkers for IBS ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure…
